{"id":7150,"date":"2025-12-13T13:00:08","date_gmt":"2025-12-13T13:00:08","guid":{"rendered":"https:\/\/autism.fratnow.com\/blog\/?p=7150"},"modified":"2025-12-13T10:16:48","modified_gmt":"2025-12-13T10:16:48","slug":"leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies","status":"publish","type":"post","link":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/","title":{"rendered":"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?"},"content":{"rendered":"

[vc_row][vc_column][vc_single_image image=”7153″ img_size=”full”][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text single_style=””]<\/p>\n

\n

Introduction<\/h2>\n

If you or a loved one is navigating the complex world of reduced folates, you\u2019ve probably heard the debate: \u201cWhich form is better?\u201d For most people, the active form\u20145-methyltetrahydrofolate (5-MTHF)\u2014is often the go to supplement. It\u2019s the ready-to-use form your body circulates and uses for crucial processes like mood regulation and heart health.<\/p>\n

But there\u2019s a specific, and often overlooked, scenario where the script may flip entirely. For individuals with a condition involving folate receptor autoantibodies (FRAAs)<\/a><\/strong>, a different form of folate called leucovorin (or folinic acid)<\/strong> may offer a better alternative.<\/p>\n

Let\u2019s break down the science into a clear, compelling story of why, in this case, leucovorin has been the product of choice.<\/p>\n

First Step: Understanding Folate Receptor Autoantibodies<\/h2>\n

Imagine your body\u2019s cells have special, high-security doors called Folate Receptor Alpha (FR\u03b1)<\/strong>. Their main job is to usher folate\u2014a critical B vitamin\u2014into some of your most important tissues: your brain, spinal fluid, and placenta<\/strong>.<\/p>\n

Now, imagine your immune system gets confused. It starts making \u201ckeys\u201d (autoantibodies) that jam these locks instead of opening them. This is exactly what happens with folate receptor autoantibodies (FRAAs)<\/strong>. The doors become blocked. Folate piles up in the bloodstream but can\u2019t get inside the cells that desperately need it, especially in the brain.<\/p>\n

The result is a paradoxical state: normal folate blood levels in the body, but a brain starving of folate<\/strong>. This is linked to a diagnosis called Cerebral Folate Deficiency Syndrome (CFDS)<\/a><\/strong>, which can manifest as developmental delays, autism spectrum features, seizures, and other neurological issues.<\/p>\n

The Two Different Keys: 5-MTHF vs. Leucovorin<\/h2>\n

This is where the form of folate you take becomes important. Think of the two main active forms as two different keys.<\/p>\n

5-MTHF: The High-Security Key<\/h3>\n
    \n
  • This is the body\u2019s primary circulating form. It\u2019s designed perfectly to fit the high-affinity folate receptor alpha (FR\u03b1) door<\/strong>.<\/li>\n
  • The Problem:<\/b> If that door is jammed by autoantibodies, this key will not be efficient. Supplementing with high-dose 5-MTHF in this situation is like trying to unlock a deadbolt with the right key, not realizing someone has filled the lock with glue. The folate levels in the blood may go up, but the brain remains deprived of folate.<\/li>\n<\/ul>\n

    Leucovorin (Folinic Acid): The Master Utility Key<\/h3>\n
      \n
    • This form is different. While it can<\/i> fit the FR\u03b1 door, it has a special and crucial feature: it has a much stronger affinity for a completely different entrance<\/strong> called the Reduced Folate Carrier (RFC)<\/strong>.<\/li>\n
    • The RFC is like a service entrance\u2014it\u2019s not as selective or high-security, but it has a much higher traffic capacity and, most importantly, it is NOT blocked by the autoantibodies<\/strong>.<\/li>\n<\/ul>\n

      Why Leucovorin is Effective: The Clever Bypass Strategy<\/h2>\n

      Leucovorin doesn\u2019t just try to force its way through the blocked main door. It takes a smarter route. Its entry point is unique as it easily slips into cells (including those in the choroid plexus, the gateway to the brain) via the unblocked RFC service entrance<\/strong>.<\/p>\n

      Once inside, the cell\u2019s machinery quickly converts leucovorin into the very folate cofactors the brain needs, including 5,10-methylene-THF<\/strong> (for making DNA and neurotransmitters) and eventually 5-MTHF itself<\/strong>. The brain cell, now making its own 5-MTHF internally, can release this precious resource into the spinal fluid through a back door<\/strong> that doesn\u2019t involve the blocked FR\u03b1 receptor at all.<\/p>\n

      In essence, leucovorin bypasses the blocked front gate, sets up a manufacturing plant inside the cell, and distributes its workable folate from within.<\/b><\/p>\n

      Proof Is in the Outcomes<\/h2>\n

      This isn\u2019t just a theoretical concept; it is a proven in clinical practice.<\/p>\n

      Pioneering research, notably by Dr. Ramaekers and his team, has shown the efficacy of leucovorin. Children with CFDS and positive autoantibodies showed improvement<\/strong> in symptoms and spinal fluid folate levels when given leucovorin<\/strong>.<\/p>\n

      The message is clear: for this specific autoimmune blockade, you must treat the transport problem<\/strong>, not just throw more folate at it. Leucovorin is the preferred folate of choice that solves the transport puzzle.<\/p>\n

      The Takeaway: A Lesson in Precision Supplementation<\/h2>\n

      The story of leucovorin vs. 5-MTHF in the context of folate receptor autoantibodies is a powerful reminder that biochemistry is context-dependent<\/strong>.<\/p>\n

        \n
      • For the general population or those with common MTHFR gene variants,<\/strong> 5-MTHF is often the superior, direct-to-use form.<\/li>\n
      • For those with folate receptor autoantibodies (which requires specific testing, like a blood test for the antibodies via the FRAT\u00ae<\/sup> test)<\/strong>, leucovorin is the specific, preferred intervention<\/strong>.<\/li>\n<\/ul>\n

        If you suspect you or your child might have a folate-related neurological issue that hasn\u2019t responded to typical supplements, discussing folate receptor autoantibody testing with a knowledgeable healthcare provider could be a critical step. The solution may not be a different dose, but a completely different key.<\/p><\/div>\n

        [\/vc_column_text][\/vc_column][\/vc_row][vc_row el_class=”text-gray-23″][vc_column][vc_column_text single_style=””]Disclaimer:<\/strong> This information is for educational purposes and is not medical advice. Diagnosis and treatment of complex conditions like CFDS require consultation with a qualified physician.<\/em>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

        Learn why leucovorin may be more effective for those with folate receptor autoantibodies and how it helps bypass blocked folate pathways.<\/p>\n","protected":false},"author":4,"featured_media":7153,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[70],"tags":[],"yoast_head":"\nLeucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?\" \/>\n<meta property=\"og:description\" content=\"Learn why leucovorin may be more effective for those with folate receptor autoantibodies and how it helps bypass blocked folate pathways.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/\" \/>\n<meta property=\"og:site_name\" content=\"fratnow.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/autismfrat\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-13T13:00:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-13T10:16:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/12\/leucovorin-vs-5mthf-blog-listing-image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"730\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Steve Tsetsekos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?\" \/>\n<meta name=\"twitter:description\" content=\"Learn why leucovorin may be more effective for those with folate receptor autoantibodies and how it helps bypass blocked folate pathways.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/12\/leucovorin-vs-5mthf-blog-listing-image.webp\" \/>\n<meta name=\"twitter:creator\" content=\"@AutismFrat\" \/>\n<meta name=\"twitter:site\" content=\"@AutismFrat\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Tsetsekos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/\"},\"author\":{\"name\":\"Steve Tsetsekos\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/d5e4020455f25cb3768f5eb9ad5e9f1c\"},\"headline\":\"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?\",\"datePublished\":\"2025-12-13T13:00:08+00:00\",\"dateModified\":\"2025-12-13T10:16:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/\"},\"wordCount\":888,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\"},\"articleSection\":[\"Neurodiversity & Wellbeing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/\",\"name\":\"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?\",\"isPartOf\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#website\"},\"datePublished\":\"2025-12-13T13:00:08+00:00\",\"dateModified\":\"2025-12-13T10:16:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/autism.fratnow.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#website\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/\",\"name\":\"fratnow.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/autism.fratnow.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#organization\",\"name\":\"fratnow.com\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png\",\"contentUrl\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png\",\"width\":194,\"height\":66,\"caption\":\"fratnow.com\"},\"image\":{\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/autismfrat\",\"https:\/\/twitter.com\/AutismFrat\",\"https:\/\/www.linkedin.com\/company\/88011685\/admin\/\",\"https:\/\/www.instagram.com\/fratautism\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/d5e4020455f25cb3768f5eb9ad5e9f1c\",\"name\":\"Steve Tsetsekos\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg\",\"contentUrl\":\"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg\",\"caption\":\"Steve Tsetsekos\"},\"sameAs\":[\"https:\/\/autism.fratnow.com\/blog\/\"],\"url\":\"https:\/\/autism.fratnow.com\/blog\/author\/steve-tsetsekos\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/","og_locale":"en_US","og_type":"article","og_title":"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?","og_description":"Learn why leucovorin may be more effective for those with folate receptor autoantibodies and how it helps bypass blocked folate pathways.","og_url":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/","og_site_name":"fratnow.com","article_publisher":"https:\/\/www.facebook.com\/autismfrat","article_published_time":"2025-12-13T13:00:08+00:00","article_modified_time":"2025-12-13T10:16:48+00:00","og_image":[{"width":730,"height":400,"url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/12\/leucovorin-vs-5mthf-blog-listing-image.webp","type":"image\/webp"}],"author":"Steve Tsetsekos","twitter_card":"summary_large_image","twitter_title":"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?","twitter_description":"Learn why leucovorin may be more effective for those with folate receptor autoantibodies and how it helps bypass blocked folate pathways.","twitter_image":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2025\/12\/leucovorin-vs-5mthf-blog-listing-image.webp","twitter_creator":"@AutismFrat","twitter_site":"@AutismFrat","twitter_misc":{"Written by":"Steve Tsetsekos","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/#article","isPartOf":{"@id":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/"},"author":{"name":"Steve Tsetsekos","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/d5e4020455f25cb3768f5eb9ad5e9f1c"},"headline":"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?","datePublished":"2025-12-13T13:00:08+00:00","dateModified":"2025-12-13T10:16:48+00:00","mainEntityOfPage":{"@id":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/"},"wordCount":888,"commentCount":0,"publisher":{"@id":"https:\/\/autism.fratnow.com\/blog\/#organization"},"articleSection":["Neurodiversity & Wellbeing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/","url":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/","name":"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?","isPartOf":{"@id":"https:\/\/autism.fratnow.com\/blog\/#website"},"datePublished":"2025-12-13T13:00:08+00:00","dateModified":"2025-12-13T10:16:48+00:00","breadcrumb":{"@id":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/autism.fratnow.com\/blog\/leucovorin-vs-5-mthf-what-we-know-of-their-efficacy-in-those-that-have-folate-receptor-autoantibodies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/autism.fratnow.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Leucovorin vs 5-MTHF \u2013 What We Know of Their Efficacy in Those That Have Folate Receptor Autoantibodies?"}]},{"@type":"WebSite","@id":"https:\/\/autism.fratnow.com\/blog\/#website","url":"https:\/\/autism.fratnow.com\/blog\/","name":"fratnow.com","description":"","publisher":{"@id":"https:\/\/autism.fratnow.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/autism.fratnow.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/autism.fratnow.com\/blog\/#organization","name":"fratnow.com","url":"https:\/\/autism.fratnow.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png","contentUrl":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/08\/logo.png","width":194,"height":66,"caption":"fratnow.com"},"image":{"@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/autismfrat","https:\/\/twitter.com\/AutismFrat","https:\/\/www.linkedin.com\/company\/88011685\/admin\/","https:\/\/www.instagram.com\/fratautism\/"]},{"@type":"Person","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/d5e4020455f25cb3768f5eb9ad5e9f1c","name":"Steve Tsetsekos","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/autism.fratnow.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg","contentUrl":"https:\/\/autism.fratnow.com\/blog\/wp-content\/uploads\/2023\/09\/e6cec733-36d3-42ae-a0a7-986995164499_medium.jpg","caption":"Steve Tsetsekos"},"sameAs":["https:\/\/autism.fratnow.com\/blog\/"],"url":"https:\/\/autism.fratnow.com\/blog\/author\/steve-tsetsekos\/"}]}},"_links":{"self":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/7150"}],"collection":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/comments?post=7150"}],"version-history":[{"count":2,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/7150\/revisions"}],"predecessor-version":[{"id":7154,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/posts\/7150\/revisions\/7154"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/media\/7153"}],"wp:attachment":[{"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/media?parent=7150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/categories?post=7150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/autism.fratnow.com\/blog\/wp-json\/wp\/v2\/tags?post=7150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}